Bulletin
Investor Alert

AmerisourceBergen Corp.

NYS: ABC

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Jun 1, 2020, 6:12 p.m.

ABC
/zigman2/quotes/201066379/composite

$

95.15

Change

0.00 0.00%

Volume

Volume 35,529

Quotes are delayed by 20 min

/zigman2/quotes/201066379/composite

Today's close

$ 95.34

$ 95.15

Change

-0.19 -0.20%

Day low

Day high

$94.84

$95.87

Open

52 week low

52 week high

$72.06

$97.50

Open

Richard W. Gochnauer

Mr. Richard W. Gochnauer is an Independent Director at AmerisourceBergen Corp. and a Director-Leadership Board at Center For Higher Ambition. He is on the Board of Directors at AmerisourceBergen Corp., Golden State Foods Corp., Rush University Medical Center, UGI Utilities, Inc. and Vodori, Inc. Mr. Gochnauer was previously employed as an Independent Director by UGI Corp., a Chief Executive Officer & Director by United Stationers, Inc., and an Executive Vice President by The Dial Corp. He also served on the board at Fieldstone Communities, Inc. and Opportunity International, Inc. He received his undergraduate degree from Northwestern University and an MBA from Harvard University.

Transactions

Date Shares Transaction Value
05/19/2020 10,585   Disposition at $90.18 per share. 954,556
05/19/2020 10,585   Derivative/Non-derivative trans. at $37.43 per share. 396,196
06/10/2019 8,256   Disposition at $84.95 per share. 701,348
06/10/2019 8,256   Derivative/Non-derivative trans. at $27.99 per share. 231,085
05/22/2019 5,500   Disposition at $80.69 per share. 443,795
05/22/2019 5,500   Derivative/Non-derivative trans. at $27.99 per share. 153,945
03/04/2019 1,417   Derivative/Non-derivative trans. at $0 per share. 0
02/15/2019 19,922   Disposition at $86.59 per share. 1,725,046
02/15/2019 19,922   Derivative/Non-derivative trans. at $17.78 per share. 354,213
02/13/2018 2,278   Disposition at $101.13 per share. 230,375
02/13/2018 2,278   Derivative/Non-derivative trans. at $19.13 per share. 43,578
01/10/2018 2,000   Disposition at $96.54 per share. 193,080
01/10/2018 2,000   Derivative/Non-derivative trans. at $19.13 per share. 38,260
12/13/2017 2,000   Disposition at $88 per share. 176,000
12/13/2017 2,000   Derivative/Non-derivative trans. at $19.13 per share. 38,260
11/29/2017 2,000   Disposition at $85 per share. 170,000
11/29/2017 2,000   Derivative/Non-derivative trans. at $19.13 per share. 38,260
05/17/2016 6,750   Gift at $0 per share. 0
02/29/2016 2,648   Derivative/Non-derivative trans. at $0 per share. 0

Officers and Executives

Mr. Steven H. Collis
Chairman, President & Chief Executive Officer
Mr. James Francis Cleary
Chief Financial Officer & Executive Vice President
Mr. Dale B. Danilewitz
Chief Information Officer & Executive VP
Ms. Gina K. Clark
Chief Communications & Administration Officer, EVP
Ms. Leslie E. Donato
Chief Strategy Officer & Executive Vice President
Mr. Rafael Augusto Kosa Teixeira
Senior Vice President-Transformation
Ms. Kathy Habecker Gaddes
Chief Compliance Officer & Executive Officer
Mr. Sun Park
Executive Vice President
Dr. Robert P. Mauch
EVP & Group President-Pharmaceutical Distribution
Ms. Ornella Barra
Non-Independent Director
Mr. Jack F. Quinn
Treasurer & Vice President
Mr. Lazarus Krikorian
Principal Accounting Officer, SVP & Controller
Mr. Bennett S. Murphy
Vice President-Investor Relations
Ms. Silvana Battaglia
Chief Human Resources Officer & Executive VP
Mr. John G. Chou
Executive VP, Chief Legal Officer & Secretary
Mr. Dennis M. Nally
Independent Director
Mr. Henry Wadsworth McGee
Independent Director
Mr. Richard W. Gochnauer
Independent Director
Dr. Jane Ellen Henney
Lead Independent Director
Ms. Kathleen W. Hyle
Independent Director
Mr. Michael J. Long
Independent Director
Mr. Lon R. Greenberg
Independent Director
Mr. D. Mark Durcan
Independent Director
Link to MarketWatch's Slice.